Woodmont Investment Counsel LLC Pfizer Inc Transaction History

Woodmont Investment Counsel LLC

$1.32 Billion
Q3 2024

A detailed history of Woodmont Investment Counsel LLC transactions in Pfizer Inc stock. As of the latest transaction made, Woodmont Investment Counsel LLC holds 227,489 shares of PFE stock, worth $6 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

227,489

Previous 162,065 40.37%

Holding current value

$6 Million

Previous $4.53 Million 45.19%

% of portfolio

0.5%

Previous 0.35%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$27.7 - $31.39 $1.81 Million - $2.05 Million	65,424 Added 40.37%	227,489 $6.58 Million
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $1.06 Million - $1.24 Million	42,011 Added 34.99%	162,065 $4.53 Million
Q1 2024 Apr 18, 2024	BUY	$25.89 - $29.73 $333,540 - $383,011	12,883 Added 12.02%	120,054 $3.33 Million
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $747,239 - $970,582	-28,597 Reduced 21.06%	107,171 $3.09 Million
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $174,184 - $203,604	5,428 Added 4.16%	135,768 $4.5 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $51,687 - $59,801	-1,431 Reduced 1.09%	130,340 $4.78 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $90,242 - $117,482	-2,291 Reduced 1.71%	131,771 $5.38 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $22,378 - $29,212	-536 Reduced 0.4%	134,062 $6.87 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $392,395 - $479,017	8,967 Added 7.14%	134,598 $5.89 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $128,143 - $151,938	2,754 Added 2.24%	125,631 $6.59 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $854,244 - $1.06 Million	18,672 Added 17.92%	122,877 $6.36 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $41,815 - $61,985	1,012 Added 0.98%	104,205 $6.15 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $78,971 - $101,445	2,012 Added 1.99%	103,193 $4.44 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $105,180 - $119,151	2,929 Added 2.98%	101,181 $3.96 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $213,063 - $240,292	6,362 Added 6.92%	98,252 $3.56 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $304,409 - $387,083	9,095 Added 10.98%	91,890 $3.38 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $28,416 - $33,338	895 Added 1.09%	82,795 $3.04 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $147,738 - $179,228	4,905 Added 6.37%	81,900 $2.68 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $370,067 - $528,746	13,691 Added 21.63%	76,995 $2.51 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $91,353 - $103,674	2,775 Added 4.58%	63,304 $2.48 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $204,232 - $264,829	6,286 Added 11.59%	60,529 $2.18 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $33,282 - $37,368	900 Added 1.69%	54,243 $2.35 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $6,187 - $6,798	165 Added 0.31%	53,343 $2.27 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $242,207 - $276,142	-6,296 Reduced 10.59%	53,178 $2.32 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $110,131 - $133,582	-3,195 Reduced 5.1%	59,474 $2.62 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $39,147 - $41,734	-1,187 Reduced 1.86%	62,669 $2.27 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $187,726 - $217,788	-5,883 Reduced 8.44%	63,856 $2.27 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $9,578 - $10,163	-288 Reduced 0.41%	69,739 $2.53 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $2.17 Million - $2.39 Million	70,027	70,027 $2.5 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodmont Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Woodmont Investment Counsel LLC with notifications on news.

Account

Woodmont Investment Counsel LLC Pfizer Inc Transaction History